JP Morgan Maintains Underweight on Doximity, Raises Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anne Samuel has maintained an Underweight rating on Doximity (NYSE:DOCS) but raised the price target from $22 to $25.

March 15, 2024 | 2:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan has maintained an Underweight rating on Doximity but increased the price target from $22 to $25.
The maintenance of an Underweight rating suggests caution or a negative outlook on the stock by JP Morgan. However, the increase in the price target from $22 to $25 indicates a slightly more positive view on the stock's valuation or future performance than previously held. This mixed signal could lead to short-term uncertainty among investors, potentially causing minor fluctuations in the stock price as the market digests this information.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100